Equities researchers at William Blair issued their FY2025 EPS estimates for VSE in a research note issued on Monday, January 27th. William Blair analyst L. Dipalma anticipates that the construction ...
AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq by $4 billion.
Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators.
Stephanie Braming, global head of William Blair Investment Management, plans to retire in the fourth quarter, a news release ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 2.08% of ...
Stock analysts at William Blair dropped their Q1 2025 earnings per share estimates for GE Vernova in a research report issued ...
William Blair downgraded Charles River (CRL) to Market Perform from Outperform without a price target “There is simply too much working against Charles River in the near term to make the stock ...
Neuronetics Inc (STIM) stock saw a modest uptick, ending the day at $3.01 which represents a slight increase of $0.47 or 18.50% from the prior close of $2.54. The stock opened at $2.67 and touched a ...
American Express beat expectations for fourth-quarter revenue on Friday, as more consumers swiped its cards during the ...
American Express (NYSE:AXP)‘s stock had its “outperform” rating reaffirmed by analysts at William Blair in a research report issued on Monday,RTT News reports. William Blair also issued estimates for ...